More from Renaissance Capital
Referenced Stocks

KYTHERA Biopharma sets terms for $60 million IPO

By Renaissance Capital,  September 24, 2012, 05:33:03 PM EDT

KYTHERA Biopharmaceuticals, a biotech developing an injection to reduce fat around the chin, announced terms for its IPO on Monday. The Calabasas, CA-based company plans to raise $60 million by offering 4.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, KYTHERA Biopharmaceuticals would command a fully diluted market value of $275 million. KYTHERA Biopharmaceuticals, which was founded in 2005 and booked $26 million in sales for the 12 months ended 6/30/2012, plans to list on the NASDAQ under the symbol KYTH. J.P. Morgan and Goldman Sachs are the joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: KYTH



Latest News Video

Tornado Outbreak Hits Midwest, 1 Death Reported
Tornado Outbreak Hits Midwest, 1 De...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.43 0.07  0.52%
CSCO $ 24.24 0.35  1.48%
MSFT $ 34.87 0.79  2.32%
F $ 15.08 0.44  3.01%
ARUN $ 13.10 4.51  25.61%
SIRI $ 3.50 0.05  1.45%
GE $ 23.46 0.19  0.82%
S $ 7.32 0.04  0.55%